2021
DOI: 10.5152/tud.2020.20343
|View full text |Cite
|
Sign up to set email alerts
|

Evidence-based protocol-led management of renal angiomyolipoma: A review of literature

Abstract: Ali Serdar Gözen, et al.; Robot-assisted vasovasostomy and vasoepididymostomy: Current status and review of the literature.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
16
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(18 citation statements)
references
References 0 publications
0
16
0
1
Order By: Relevance
“…Arterial embolisation therapy is considered the first line of therapy for patients with AML presenting with acute haemorrhage. Selective arterial embolisation has been shown to be safe and effective therapy for actively haemorrhaging AMLs 14–16. Arterial embolisation therapy has success rates emergently controlling haemorrhage reported over 95% 17.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Arterial embolisation therapy is considered the first line of therapy for patients with AML presenting with acute haemorrhage. Selective arterial embolisation has been shown to be safe and effective therapy for actively haemorrhaging AMLs 14–16. Arterial embolisation therapy has success rates emergently controlling haemorrhage reported over 95% 17.…”
Section: Discussionmentioning
confidence: 99%
“…It can reach most AMLs including some involving the renal hilum. It limits blood loss, and has been shown to decrease the need for surgery, as well as improve outcomes of subsequent nephron-sparing surgery should it be necessary 14–16. There are concerns that patients who are treated with embolisation therapy may need reintervention for further bleeding or growth of the AML.…”
Section: Discussionmentioning
confidence: 99%
“…Systemic treatments are currently recommended as the first-line treatment for asymptomatic TSC patients to preserve renal parenchyma, reduce rate of secondary complications, and/or reduce the need for continued interventions that may further compromise renal function. [15][16][17] While four study participants (patients 3, 4, 12, 19) managed their AMLs through localized therapy, they were not candidates for everolimus therapy or active surveillance, as they had either symptomatic AMLs and/or extremely high-risk AMLs.…”
Section: Tsc-related Angiomyolipomamentioning
confidence: 99%
“…These findings suggest that active surveillance in low-risk, asymptomatic AML patients is a viable option, which aligns with the current strategy recommendations. 15,16 Refer to Figure 2 for a management algorithm for TSCassociated AMLs.…”
Section: Tsc-related Angiomyolipomamentioning
confidence: 99%
See 1 more Smart Citation